Grant Funding
Gilead Sciences funds nonprofit-led, innovative research and projects advancing health equity in HIV, liver disease, oncology, and chronic inflammatory diseases worldwide.
Funder: Gilead Sciences
Due Dates: Rolling (year-round; applications must be submitted at least 6 weeks before project start)
Funding Amounts: No set minimum or maximum; project budgets required; funding is typically for up to one year.
Summary: Supports nonprofit-led, innovative projects that advance health equity and improve healthcare infrastructure in HIV, liver disease, oncology, and chronic inflammatory diseases worldwide.
Key Information: Only nonprofit organizations are eligible; no retroactive funding; applications reviewed in ~6–12 weeks.
Description
Gilead Sciences' grant funding program supports community-informed, data-driven initiatives that strengthen healthcare infrastructure and deliver education, prevention, and care to vulnerable populations globally. Funding is available for innovative, high-impact projects in core therapeutic areas, including HIV/AIDS, liver diseases (such as hepatitis B, C, D, and primary biliary cholangitis), oncology (hematology and solid tumors), and chronic inflammatory and respiratory diseases. The program prioritizes projects that demonstrate measurable outcomes, advance health equity, and address health disparities through education, prevention, care options, and community engagement.
